| Risks and benefits of commonly used herbal medicines in Mexico L Rodriguez-Fragoso, J Reyes-Esparza, SW Burchiel, D Herrera-Ruiz, ... Toxicology and applied pharmacology 227 (1), 125-135, 2008 | 368 | 2008 |
| Spatial expression patterns of peptide transporters in the human and rat gastrointestinal tracts, Caco-2 In Vitro cell culture model, and multiple human tissues D Herrera-Ruiz, Q Wang, TJ Cook, GT Knipp, OS Gudmundsson, ... Aaps Pharmsci 3, 100-111, 2001 | 168 | 2001 |
| Current perspectives on established and putative mammalian oligopeptide transporters D Herrera‐Ruiz, GT Knipp Journal of pharmaceutical sciences 92 (4), 691-714, 2003 | 144 | 2003 |
| The functional evaluation of human peptide/histidine transporter 1 (hPHT1) in transiently transfected COS-7 cells RK Bhardwaj, D Herrera-Ruiz, N Eltoukhy, M Saad, GT Knipp European journal of pharmaceutical sciences 27 (5), 533-542, 2006 | 105 | 2006 |
| Cocrystals of Active Pharmaceutical Ingredients Praziquantel in Combination with Oxalic, Malonic, Succinic, Maleic, Fumaric, Glutaric, Adipic, And Pimelic Acids JC Espinosa-Lara, D Guzman-Villanueva, JI Arenas-García, ... Crystal growth & design 13 (1), 169-185, 2013 | 103 | 2013 |
| Formulation approaches to short interfering RNA and MicroRNA: challenges and implications D Guzman-Villanueva, IM El-Sherbiny, D Herrera-Ruiz, AV Vlassov, ... Journal of pharmaceutical sciences 101 (11), 4046-4066, 2012 | 95 | 2012 |
| Design and In Vitro Evaluation of a New Nano‐Microparticulate System for Enhanced Aqueous‐Phase Solubility of Curcumin D Guzman-Villanueva, IM El-Sherbiny, D Herrera-Ruiz, HDC Smyth BioMed research international 2013 (1), 724763, 2013 | 90 | 2013 |
| Co-crystals of active pharmaceutical ingredients-acetazolamide JI Arenas-Garcia, D Herrera-Ruiz, K Mondragón-Vásquez, ... Crystal growth & design 10 (8), 3732-3742, 2010 | 88 | 2010 |
| Chiral Resolution of RS-Praziquantel via Diastereomeric Co-Crystal Pair Formation with l-Malic Acid O Sánchez-Guadarrama, F Mendoza-Navarro, A Cedillo-Cruz, ... Crystal Growth & Design 16 (1), 307-314, 2016 | 86 | 2016 |
| Nitazoxanide cocrystals in combination with succinic, glutaric, and 2, 5-dihydroxybenzoic acid BC Felix-Sonda, J Rivera-Islas, D Herrera-Ruiz, H Morales-Rojas, ... Crystal growth & design 14 (3), 1086-1102, 2014 | 50 | 2014 |
| Modification of the supramolecular hydrogen-bonding patterns of acetazolamide in the presence of different cocrystal formers: 3: 1, 2: 1, 1: 1, and 1: 2 cocrystals from … JI Arenas-Garcia, D Herrera-Ruiz, K Mondragon-Vasquez, ... Crystal growth & design 12 (2), 811-824, 2012 | 48 | 2012 |
| Overcoming Lung Clearance Mechanisms for Controlled Release Drug Delivery IB El-Sherbiny, G D, D Herrera, S HDC Controlled Pulmonary Drug Delivery, 101-126, 2011 | 48 | 2011 |
| A twist in cocrystals of salts: changes in packing and chloride coordination lead to opposite trends in the biopharmaceutical performance of fluoroquinolone hydrochloride … JM Martínez-Alejo, JG Dominguez-Chavez, J Rivera-Islas, D Herrera-Ruiz, ... Crystal growth & design 14 (6), 3078-3095, 2014 | 43 | 2014 |
| Selective isolation of polycyclic aromatic hydrocarbons by self-assembly of a tunable N→ B clathrate AD Herrera-España, G Campillo-Alvarado, P Román-Bravo, ... Crystal Growth & Design 15 (4), 1572-1576, 2015 | 37 | 2015 |
| Delineation of human peptide transporter 1 (hPepT1)-mediated uptake and transport of substrates with varying transporter affinities utilizing stably transfected hPepT1/Madin … RK Bhardwaj, D Herrera-Ruiz, PJ Sinko, OS Gudmundsson, G Knipp The Journal of pharmacology and experimental therapeutics 314 (3), 1093-1100, 2005 | 37 | 2005 |
| Dissolution advantage of nitazoxanide cocrystals in the presence of cellulosic polymers R Salas-Zúñiga, C Rodríguez-Ruiz, H Höpfl, H Morales-Rojas, ... Pharmaceutics 12 (1), 23, 2019 | 35 | 2019 |
| Interrelation of the dissolution behavior and solid-state features of acetazolamide cocrystals JI Arenas-García, D Herrera-Ruiz, H Morales-Rojas, H Höpfl European Journal of Pharmaceutical Sciences 96, 299-308, 2017 | 35 | 2017 |
| On molecular complexes derived from amino acids and nicotinamides in combination with boronic acids J Hernández-Paredes, AL Olvera-Tapia, JI Arenas-García, H Höpfl, ... CrystEngComm 17 (28), 5166-5186, 2015 | 34 | 2015 |
| Enhanced cellular uptake and gene silencing activity of siRNA molecules mediated by chitosan-derivative nanocomplexes D Guzman-Villanueva, IM El-Sherbiny, AV Vlassov, D Herrera-Ruiz, ... International journal of pharmaceutics 473 (1-2), 579-590, 2014 | 29 | 2014 |
| Expression of PPAR, RXR isoforms and fatty acid transporting proteins in the rat and human gastrointestinal tracts Q Wang, D Herrera-Ruiz, AS Mathis, TJ Cook, RK Bhardwaj, GT Knipp Journal of pharmaceutical sciences 94 (2), 363-372, 2005 | 29 | 2005 |